The process of randomly assigning study participants to different treatment arms in a clinical trial is called randomization. In order to avoid a potential bias, the allocation is not performed by an investigator or a sponsor’s representative. An investigator who is convinced of the investigational drug’s effectiveness might (possibly unintentionally) assign certain patients to the…
